Dyne Therapeutics, Inc.

Direct answer

Dyne Therapeutics, Inc. is publicly traded on NASDAQ under the ticker DYN.

Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and...

Can you invest in Dyne Therapeutics, Inc.?

Yes. Dyne Therapeutics, Inc. is publicly traded on NASDAQ under the ticker DYN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Dyne Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.